| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.350 | 4.639 | 4.378 | 6.362 | 6.853 | 6.202 | 6.065 | 11.153 | 6.065 | 7.179 |
| Total Income - EUR | 1.350 | 4.639 | 4.378 | 6.362 | 6.853 | 6.202 | 6.065 | 11.153 | 6.065 | 7.179 |
| Total Expenses - EUR | 5.357 | 4.266 | 4.684 | 4.833 | 6.717 | 8.188 | 6.319 | 8.864 | 14.119 | 7.632 |
| Gross Profit/Loss - EUR | -4.007 | 373 | -306 | 1.529 | 137 | -1.985 | -255 | 2.289 | -8.054 | -453 |
| Net Profit/Loss - EUR | -4.047 | 234 | -437 | 1.338 | -69 | -2.172 | -437 | 1.954 | -8.115 | -453 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
Check the financial reports for the company - Diagra Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.495 | 4.320 | 4.120 | 4.936 | 4.653 | 4.380 | 4.117 | 3.945 | 3.762 | 3.552 |
| Current Assets | 4.360 | 4.294 | 4.286 | 4.648 | 4.629 | 2.918 | 2.666 | 4.398 | 3.395 | 1.845 |
| Inventories | 0 | 334 | 328 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.272 | 2.708 | 2.964 | 2.964 | 3.716 | 1.712 | 1.444 | 2.310 | 1.858 | 935 |
| Cash | 1.088 | 1.252 | 993 | 1.684 | 913 | 1.206 | 1.223 | 2.089 | 1.536 | 910 |
| Shareholders Funds | 1.757 | 1.973 | 1.502 | 2.813 | 2.689 | 467 | 20 | 1.974 | -6.147 | -6.565 |
| Social Capital | 18.241 | 18.055 | 17.750 | 17.424 | 17.086 | 16.763 | 16.391 | 16.442 | 16.392 | 16.300 |
| Debts | 7.099 | 6.641 | 6.904 | 6.771 | 6.592 | 6.831 | 6.763 | 6.370 | 13.304 | 11.962 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Diagra Srl